TrialJournal of neuro-oncology2017

Health-related quality of life, cognitive screening, and functional status in a randomized phase III trial (EF-14) of tumor treating fields with temozolomide compared to temozolomide alone in newly diagnosed glioblastoma.

Jay-Jiguang Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.